Brown-Vialetto-Van Laere and Fazio Londe syndromes: Defects of riboflavin transport with biochemical similarities to multiple acyl-CoA dehydrogenation defects (MADD): See original article DOI 10.1007/s10545-012-9513-y
The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria
Amendt BA, Rhead WJ (1986) The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria. J Clin Investig 72:208-213
Early use of high-dose riboflavin in a case of Brown-Vialetto-Van Laere syndrome
22098162 10.1111/j.1469-8749.2011.04142.x
Anand G, Hasan N, Jayapal S, et al.(2012) Early use of high-dose riboflavin in a case of Brown-Vialetto-Van Laere syndrome. Dev Med Child Neurol 54:187-189
Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: A new inborn error of metabolism with potential treatment
Bosch AM, Abeling NG, Ijlst L, et al.(2011) Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. J Inherit Metab Dis 34:159-164
Riboflavin-responsive lipid storage myopathy and glutaric aciduria type II of early adult onset
3951704 10.1212/WNL.36.3.367
De Visser M, Scholte HR, Schutgens RBH, et al.(1986) Riboflavin- responsive lipid storage myopathy and glutaric aciduria type II of early adult onset. Neurology 36:367-372
Normalization of short-chain acylcoenzyme A dehydrogenase after riboflavin treatment in a girl with multiple acylcoenzyme A dehydrogenase- deficient myopathy
DiDonato S, Gellera C, Peluchetti D, et al.(1989) Normalization of short-chain acylcoenzyme A dehydrogenase after riboflavin treatment in a girl with multiple acylcoenzyme A dehydrogenase-deficient myopathy. Ann Neurol 25:479-484
Brown-Vialetto-Van Laere syndrome; Variability in age of onset and disease progression highlighting the phenotypic overlap with Fazio-Londe disease
16122634 10.1016/j.braindev.2004.10.003
Dipti S, Childs A, Livingstone JH, et al.(2005) Brown-Vialetto-Van Laere syndrome; variability in age of onset and disease progression highlighting the phenotypic overlap with Fazio-Londe disease. Brain Dev 27:443-446
Green P, Wiseman M, Crow YJ, et al.(2010) Brown-Vialetto-Van Laere syndrome, a pontobulbar palsy with deafness is caused by mutations in c20orf54. Am J Hum Genet 86:485-489
Gregersen N, Wintzensen H, Kolvraa S, et al.(1982) C6-C10 dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects. Pediatr Res 16:861-868
Impaired riboflavin transport due to missense mutations in SLC52A2 cause Brown-Vialetto-Van Laere syndrome
doi: 10.1007/s10545-012-9513-y
Haack TB, Makowski C, Yao Y,, et al.(2012) Impaired riboflavin transport due to missense mutations in SLC52A2 cause Brown-Vialetto-Van Laere syndrome. J Inherit Metab Dis. doi: 10.1007/s10545-012-9513-y
Maternal riboflavin deficiency resulting in transient neonatal-onset glutaric aciduria type 2 is caused by a microdeletion in the riboflavin transporter gene GPR172B
Ho G, Yonezawa A, Masuda S, et al.(2011) Maternal riboflavin deficiency resulting in transient neonatal-onset glutaric aciduria type 2 is caused by a microdeletion in the riboflavin transporter gene GPR172B. Hum Mutat 32:E1976-E1984